title: Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancer.
abstract: OBJECTIVE
  To examine the relation between the replication error (RER) phenotype and other genetic events, clinical features, and long term survival in patients with Dukes' B stage II (T3,N0,M0) colorectal cancer.
  
  
  METHODS
  RER phenotype was investigated in 159 patients by PCR amplification of microsatellite marker loci on chromosomes 5q, 17p, 17q, and 18q from tumour DNA extracted from archival tissue. Data on activating c-Ki-ras mutations were available from a previous study. Immunohistochemical detection of p53 and c-erbB-2 expression was performed on paraffin wax embedded tissue.
  
  
  RESULTS
  Of 159 colorectal cancers studied, 22 (14%) were RER+ while 137 (86%) were RER- for two or more loci. RER+ tumours were more commonly located in the right colon, tended to be larger than RER- tumours, and were more often poorly differentiated than RER- cancers. No significant associations were seen between RER status and the presence of a mutant c-Ki-ras gene, or between RER status and p53, c-erbB-2, or c-myc gene expression. Univariate survival analysis showed that outcome was similar in RER+ and RER- cases. Multivariate survival analysis showed that the relative risk of death for patients with RER+ cancers was 0.95 that of patients with RER- cancers.
  
  
  CONCLUSIONS
  The results suggest that, while the RER phenotype may be associated with some differences in tumour pathology (site, size, differentiation), it is not associated with the genetic alterations studied or with significant differences in long term survival.
authors.affiliation: Department of Pathology, Royal College of Surgeons in Ireland, Dublin, Republic of Ireland.
authors.forename: B
authors.initials: B
authors.lastname: Curran
authors.forename: K
authors.initials: K
authors.lastname: Lenehan
authors.forename: H
authors.initials: H
authors.lastname: Mulcahy
authors.forename: O
authors.initials: O
authors.lastname: Tighe
authors.forename: M A
authors.initials: MA
authors.lastname: Bennett
authors.forename: E W
authors.initials: EW
authors.lastname: Kay
authors.forename: D P
authors.initials: DP
authors.lastname: O'Donoghue
authors.forename: M
authors.initials: M
authors.lastname: Leader
authors.forename: D T
authors.initials: DT
authors.lastname: Croke
mesh_terms: D000368:Aged; D015179:Colorectal Neoplasms / Q000235:genetics* / Q000473:pathology*; D004261:DNA Replication / Q000235:genetics*; D005260:Female; D011905:Genes, ras; D005819:Genetic Markers; D006801:Humans; D008297:Male; D018895:Microsatellite Repeats / Q000235:genetics; D008875:Middle Aged; D009154:Mutation; D009367:Neoplasm Staging; D016271:Proto-Oncogene Proteins c-myc / Q000032:analysis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D018709:Statistics, Nonparametric; D016019:Survival Analysis; D016159:Tumor Suppressor Protein p53 / Q000032:analysis
chemical_list: D005819:Genetic Markers; D016271:Proto-Oncogene Proteins c-myc; D018719:Erb-b2 Receptor Tyrosine Kinases; D016159:Tumor Suppressor Protein p53